Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
Quick Stats
Feb 02, 202662.5
AI Score
BUY0.72
Volume Ratio
Feb 11, 2026
Next Earnings
8
+ve Days (30d)
22
-ve Days (30d)
MLYS Stock Summary
Last updated Feb 02, 2026
MLYS is currently trading at $30.87, positioned above its 200-day moving average of $27.02, indicating a long-term uptrend. The stock has a 52-week range of $8.241 to $47.65.
Technical Analysis: The 50-day moving average stands at $36.33, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.732, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.116, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MLYS at 62.5/100 with a BUY recommendation.
MLYS (Mineralys Therapeutics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.732 |
| CMF (20) | 0.116 |
| ROC (10) | -5.712 |
| ADX (14) | 15.549 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.343 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -88.318 |
| MFI (14) | 33.599 |
MLYS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MLYS Price vs Max Options Open Interest
MLYS Max Change In Options Open Interest
MLYS Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Mineralys Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MLYS Moving Averages Analysis
Mineralys Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
MLYS (Mineralys Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 32.23 |
| 20 | 32.95 |
| 30 | 34.22 |
| 50 | 36.33 |
| 100 | 38.38 |
| 200 | 27.02 |
MLYS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.4 billion |
| Earnings/Share ($) | -2.81 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.3863 |
| EPS Estimate Next Year ($) | -2.2286 |
| WallStreet Target Price ($) | 50.875 |
| Most Recent Quarter |